miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.
复制标题
DOI:
10.1038/s41467-018-03348-z
复制
发表时间:
2018-03-13
影响因子:
16.6
通讯作者:
Mechta-Grigoriou F
中科院分区:
文献类型:
--
作者:
Givel AM;Kieffer Y;Scholer-Dahirel A;Sirven P;Cardon M;Pelon F;Magagna I;Gentric G;Costa A;Bonneau C;Mieulet V;Vincent-Salomon A;Mechta-Grigoriou F
High-grade serous ovarian cancers (HGSOC) have been subdivided into molecular subtypes. The mesenchymal HGSOC subgroup, defined by stromal-related gene signatures, is invariably associated with poor patient survival. We demonstrate that stroma exerts a key function in mesenchymal HGSOC. We highlight stromal heterogeneity in HGSOC by identifying four subsets of carcinoma-associated fibroblasts (CAF-S1-4). Mesenchymal HGSOC show high content in CAF-S1 fibroblasts, which exhibit immunosuppressive functions by increasing attraction, survival, and differentiation of CD25+FOXP3+ T lymphocytes. The beta isoform of the CXCL12 chemokine (CXCL12β) specifically accumulates in the immunosuppressive CAF-S1 subset through a miR-141/200a dependent-mechanism. Moreover, CXCL12β expression in CAF-S1 cells plays a crucial role in CAF-S1 immunosuppressive activity and is a reliable prognosis factor in HGSOC, in contrast to CXCL12α. Thus, our data highlight the differential regulation of the CXCL12α and CXCL12β isoforms in HGSOC, and reveal a CXCL12β-associated stromal heterogeneity and immunosuppressive environment in mesenchymal HGSOC. Cancer-associated fibroblasts (CAFs) are an important part of the tumor microenvironment. Here the authors characterize four subsets of CAFs across human samples of ovarian cancer subtypes and show in the mesenchymal subtype a specific CAF-S1 population that attracts immunosuppressive Tregs via CXCL12β.
登录
查看更多内容
影响因子:
16.6
作者:
Batista L;Bourachot B;Mateescu B;Reyal F;Mechta-Grigoriou F
通讯作者:
Mechta-Grigoriou F
DOI:
10.1007/s00262-015-1753-x
发表时间:
2015-12
期刊:
Cancer immunology, immunotherapy : CII
影响因子:
--
作者:
Knutson KL;Maurer MJ;Preston CC;Moysich KB;Goergen K;Hawthorne KM;Cunningham JM;Odunsi K;Hartmann LC;Kalli KR;Oberg AL;Goode EL
通讯作者:
Goode EL
影响因子:
45.3
作者:
Fong, Peter C.;Yap, Timothy A.;Kaye, Stan B.
通讯作者:
Kaye, Stan B.
影响因子:
10.3
作者:
Konecny, Gottfried E.;Wang, Chen;Goode, Ellen L.
通讯作者:
Goode, Ellen L.
DOI:
10.1073/pnas.1320318110
发表时间:
2013-12-10
影响因子:
11.1
作者:
Feig, Christine;Jones, James O.;Fearon, Douglas T.
通讯作者:
Fearon, Douglas T.